Coronavirus

A new CRISPR treatment that halted coronavirus transmission in human cells could be the easy-to-distribute COVID-19 drug the world needs.

Using a “chimeric” spike protein, researchers have immunized mice against multiple types of coronaviruses with one shot.

Any revised version of the Moderna COVID-19 vaccine will likely include a smaller dose, reducing side effects and increasing the supply of shots.

A mass vaccination experiment in Brazil suggests that even a moderately effective vaccine can have a dramatic effect if enough people get the shot.

An inhaled nanobody treatment for COVID-19 has shown promise in animal tests and could be a more affordable alternative to monoclonal antibody drugs.

Singapore has provisionally authorized a COVID-19 breath test that measures VOCs to deliver accurate results in just one minute.

An inhaled CRISPR treatment can be easily tweaked to attack a variety of viruses, from the one that causes the flu to the coronavirus behind COVID-19.

Australian researchers have found an immune response measurement they believe can predict protection against COVID-19.

Ohio’s vaccine lottery, which will give five vaccinated residents $1 million each, appears to have sparked the desired increase in new vaccinations.

Human challenge trials are risky, but they could help us avoid another prolonged pandemic.